Safety, Tolerability, PK and PD Study of Neu-120 in the Treatment of Levodopa-induced Dyskinesia

NCT00607451 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

8

Enrollment

INDUSTRY

Sponsor class

Conditions

Levodopa-induced Dyskinesia

Interventions

DRUG: Neu-120

Sponsor

Neurim Pharmaceuticals Ltd.